Blair William & CO Ardelyx, Inc. Transaction History
Blair William & CO
- $33.5 Billion
- Q4 2024
A detailed history of Blair William & CO transactions in Ardelyx, Inc. stock. As of the latest transaction made, Blair William & CO holds 14,785 shares of ARDX stock, worth $80,430. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,785
Previous 14,785
-0.0%
Holding current value
$80,430
Previous $101,000
24.75%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ARDX
# of Institutions
233Shares Held
150MCall Options Held
1.54MPut Options Held
3.08M-
Janus Henderson Group PLC London, X024.4MShares$133 Million0.07% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$95.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.4MShares$78.1 Million0.0% of portfolio
-
State Street Corp Boston, MA11.6MShares$63.1 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C310.3MShares$56.3 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $841M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...